11.16
0.27%
0.03
Dopo l'orario di chiusura:
11.16
Replimune Group Inc Borsa (REPL) Ultime notizie
An analyst sees good growth prospects for Replimune Group Inc (REPL) - SETE News
Point72 Asia Singapore Pte. Ltd. Takes $443,000 Position in Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat
Replimune Group (NASDAQ:REPL) Stock Price Up 3.8% on Analyst Upgrade - MarketBeat
Financial Metrics Unveiled: Replimune Group Inc (REPL)’s Key Ratios in the Spotlight - The Dwinnex
JPMorgan Chase & Co. Increases Replimune Group (NASDAQ:REPL) Price Target to $17.00 - MarketBeat
Replimune Group (NASDAQ:REPL) Given New $17.00 Price Target at JPMorgan Chase & Co. - Defense World
A stock that deserves closer examination: Replimune Group Inc (REPL) - US Post News
Rhumbline Advisers Buys 5,732 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Replimune Group, Inc. (NASDAQ:REPL) Receives Average Rating of “Buy” from Analysts - Defense World
Chief Financial Officer Hill Emily Luisa sale 8,938 shares of Replimune Group Inc [REPL] - Knox Daily
Replimune Group (NASDAQ:REPL) Shares Gap Up to $11.03 - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Shares Bought by Bank of New York Mellon Corp - Defense World
Arizona State Retirement System Takes Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group (NASDAQ:REPL) Shares Down 6.4% - Defense World
Its Stock Has Paid Off Big Time For Replimune Group Inc - SETE News
Replimune Group (NASDAQ:REPL) Rating Reiterated by HC Wainwright - Defense World
Replimune Group (NASDAQ:REPL) Shares Gap Up to $11.03 - MarketBeat
Are Replimune Group Inc’shares a good deal? - US Post News
Analytical Lens: Exploring Replimune Group Inc (REPL)’s Financial Story Through Ratios - The Dwinnex
Quest Partners LLC Acquires 3,150 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group (NASDAQ:REPL) Stock Price Down 6.4% - MarketBeat
Replimune Group (NASDAQ:REPL) Rating Reiterated by HC Wainwright - MarketBeat
Taking a Closer Look At Replimune Group Inc (REPL) Following Its Recent Trade - Knox Daily
Replimune Presents Primary Analysis Data from IGNYTE Clinical Trial of RP1 Combined with Nivolumab in Anti-PD1 Failed Melanoma at European Society for Medical Oncology (ESMO) Congress 2024 - StockTitan
Replimune Group, Inc. (NASDAQ:REPL) Shares Bought by Acadian Asset Management LLC - MarketBeat
Replimune Presents Primary Analysis Data from IGNYTE Clinical Trial of RP1 Combined with Nivolumab in Anti-PD1 Failed Melanoma at European Society for Medical Oncology (ESMO) Congress 2024 - ForexTV.com
Acadian Asset Management LLC Buys 71,867 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Shares Bought by TD Asset Management Inc - Defense World
Los Angeles Capital Management LLC Has $646,000 Stock Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group (NASDAQ:REPL) Stock Price Up 7.4% - MarketBeat
Q2 2025 Earnings Forecast for Replimune Group, Inc. Issued By HC Wainwright (NASDAQ:REPL) - MarketBeat
Financial Snapshot: Analyzing Replimune Group Inc (REPL)’s Key Ratio Metrics - The Dwinnex
Replimune Group (NASDAQ:REPL) Given Buy Rating at HC Wainwright - Defense World
Zurcher Kantonalbank Zurich Cantonalbank Sells 3,497 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Objective long/short (REPL) Report - Stock Traders Daily
ROTH MKM analysts initates a Buy rating for Replimune Group Inc (REPL) - Knox Daily
H.C. Wainwright maintains Buy rating on Replimune shares after FDA meeting - Investing.com Canada
HC Wainwright Reiterates Buy Rating for Replimune Group (NASDAQ:REPL) - MarketBeat
What was Replimune Group Inc (REPL)’s performance in the last session? - US Post News
MA Biotech Reports Positive Meeting with FDA - Streetwise Reports
Replimune stock target, buy rating maintained on positive FDA pre-BLA meeting - Investing.com Canada
Replimune Announces Positive Pre-BLA Meeting with FDA and Confirms BLA Submission On Track for 2H 2024 - StockTitan
Replimune Group announces results of annual stockholder meeting - Investing.com
Signaturefd LLC Cuts Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group announces results of annual stockholder meeting - Investing.com India
Replimune Group Inc [REPL] stock for 90,989 USD was sold by Hill Emily Luisa - Knox Daily
REPLReplimune Group, Inc. Latest Stock News & Market Updates - StockTitan
Replimune appoints industry veteran to board of directors By Investing.com - Investing.com Canada
Replimune appoints industry veteran to board of directors - Investing.com
Replimune appoints industry veteran to board of directors By Investing.com - Investing.com UK
Stockholders Vote to Elect Madhavan Balachandran to Board of Directors - StockTitan
Replimune: Strong Data In A Highly Differentiated Space (NASDAQ:REPL) - Seeking Alpha
REPL’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Replimune Group (NASDAQ:REPL) Trading Down 4.8% - Defense World
Replimune Group (NASDAQ:REPL) Shares Down 4.8% - MarketBeat
Equities Analysts Set Expectations for Replimune Group, Inc.'s Q2 2025 Earnings (NASDAQ:REPL) - MarketBeat
Analysts Set Expectations for Replimune Group, Inc.’s Q2 2025 Earnings (NASDAQ:REPL) - Defense World
Replimune Group (NASDAQ:REPL) Upgraded at Roth Capital - MarketBeat
Equities Analysts Issue Forecasts for Replimune Group, Inc.'s Q3 2025 Earnings (NASDAQ:REPL) - MarketBeat
Replimune Group, Inc. (NASDAQ:REPL) Receives Consensus Rating of “Buy” from Analysts - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Given Average Rating of "Buy" by Analysts - MarketBeat
Replimune Group, Inc. (NASDAQ:REPL) Expected to Earn Q3 2025 Earnings of ($0.88) Per Share - Defense World
Replimune Group (NASDAQ:REPL) Stock Rating Upgraded by Roth Capital - Defense World
Replimune Group Inc (REPL) Stock: A Year of Market Fluctuations - The InvestChronicle
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):